Examkin

Soru

Zorluk: OrtaGynecologic Oncology

A 45-year-old woman, gravida 3, para 3, presents to the clinic to discuss the results of her recent routine cervical cancer screening. Her Pap smear results are reported as "Atypical Glandular Cells, favor neoplastic" (AGC-neoplastic). She is asymptomatic, has regular 28-day menstrual cycles, and her pelvic examination is unremarkable. She underwent a bilateral tubal ligation 10 years ago and does not desire future fertility. Throughout the course of her care, subsequent evaluations confirm a final diagnosis of cervical adenocarcinoma in situ (AIS) with no evidence of invasive cancer. Arrange the following clinical interventions in the standard chronological sequence for the complete evaluation and definitive management of this patient.

  1. 1Colposcopy with endocervical curettage and endometrial biopsy
  2. 2Diagnostic excisional procedure (e.g., cold knife conization)
  3. 3Total extrafascial hysterectomy
  4. 4Long-term surveillance with HPV-based testing

Cevap

The correct sequence of management is: (1) Colposcopy with endocervical curettage and endometrial biopsy, (2) Diagnostic excisional procedure, (3) Total extrafascial hysterectomy, and (4) Long-term surveillance with HPV-based testing.
The clinical management of Atypical Glandular Cells (AGC) on cervical cytology requires a systematic, escalating approach to rule out invasive malignancy. Because glandular cells can originate from the cervical canal or the uterine cavity, the very first step in a patient age 35 or older is simultaneous colposcopy, endocervical curettage (ECC), and endometrial biopsy. If these initial non-excisional biopsies indicate AIS, or if the cytology was 'AGC-favor neoplastic' (which carries a high risk of malignancy), guidelines mandate a diagnostic excisional procedure—typically a cold knife conization. The conization is necessary to preserve tissue margins and rule out occult invasive adenocarcinoma. Once invasive cancer is confidently ruled out via the cone biopsy, simple (extrafascial) hysterectomy serves as the definitive treatment of choice for AIS in patients who have completed childbearing. Finally, even after a hysterectomy for AIS, patients require long-term surveillance with vaginal vault HPV-based testing to monitor for recurrence.

Adım Adım Çözüm

1
Perform colposcopy, endocervical curettage, and endometrial biopsy.
Initial histologic evaluation of the lower genital tract and endometrium is completed.
Required as the first triage step to locate the source of glandular abnormalities in women aged 35 and older.
2
Perform a diagnostic excisional procedure (cold knife conization).
Provides intact tissue architecture to confirm AIS and rule out invasive adenocarcinoma.
Simple biopsies cannot reliably exclude invasive disease, which would dictate a completely different surgical approach (radical hysterectomy).
3
Perform a total extrafascial hysterectomy.
The entire cervix and uterus are removed, definitively treating the AIS.
This is the standard of care for definitive treatment of AIS in a woman who does not desire future fertility.
4
Initiate long-term surveillance.
The patient is monitored for disease recurrence.
Patients with a history of AIS remain at risk for vaginal recurrences and require ongoing HPV-based follow-up.

Anahtar Kavram

The standard step-wise evaluation and management pathway for Atypical Glandular Cells (AGC) leading to a diagnosis of Adenocarcinoma in situ (AIS).
Bu soruyu puanla

Konular

Gynecologic Oncology

Bu konudan daha fazla soru